Skip to content
← Langerhans Cell Histiocytosis

FOR PATIENTS · SOURCE READING

Skin Lesions

Source: Langerhans Cell Histiocytosis Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: June 6, 2024 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.

Context: Treatment of LCH in Adults

Treatment for LCH that affects only the skin in adults may include:

Source links and citations

Surgery.

Source links and citations

Steroid or other drug therapy (tacrolimus or imiquimod) applied or injected into the skin.

Source links and citations

Photodynamic therapy with psoralen and ultraviolet A (PUVA) radiation.

Source links and citations

UVB radiation therapy.

Source links and citations

Chemotherapy or immunotherapy given by mouth, such as methotrexate, thalidomide, or hydroxyurea.

Source links and citations

Treatment for LCH that affects the skin and other body systems in adults may include:

Chemotherapy.

Preserved source evidence · Independent clinical review pending · Not medical advice